ArticleJournal of personalized medicine2021

Multiple Single Nucleotide Polymorphism Testing Improves the Prediction of Diabetic Retinopathy Risk with Type 2 Diabetes Mellitus.

Yu-Ting Hsiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.